Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Imminent launch of Novartis' Alzheimer's disease therapy

Aug. 12, 1997

First approval for Elan's Diastat

Aug. 8, 1997

Paclitaxel approved by FDA for AIDS-related KS

Aug. 6, 1997

FDA approves first novel treatment for tremor in 30 years

Aug. 6, 1997

Crinone approved in U.S. for additional indication

Aug. 4, 1997

Grepafloxacin receives first approval in Germany

Aug. 4, 1997

Iloprost reverses 5-FU-induced delayed wound healing in rats

Aug. 4, 1997

New application for long-established local anesthetic

Aug. 1, 1997

FDA approves Niaspan for the treatment of mixed lipid disorders

July 30, 1997

Prosorba column trial for rheumatoid arthritis to continue

July 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...